Interstitial cystitis (IC) is a chronic bladder disease with devastating effects on the lives of approximately 450,000 people in the United States. The etiology of IC is unknown, and there is currently no reliably effective treatment. It is therefore important to continue to search for a cause of this debilitating disorder, in order to systematically devise an effective therapy. Preliminary data indicate the presence of a low molecular weight, heat stable, factor(s) in the urine of IC patients that inhibits proliferation of cultured normal adult human bladder epithelial cells. Because a damaged bladder epithelium is a central finding in IC, it is possible that this factor(s) contributes to the pathogenesis of this disease. Substantial progress has been made in the purification and characterization of this antiproliferative factor(s). Preliminary characterization including trypsin treatment and isoelectric point determination indicates that this factor is probably an acidic peptide. Based upon this information, a sequential purification scheme has been devised that utilizes specific chromatographic methods to obtain an approximately 50-fold increase in specific activity of this peptide(s) with an active fraction that contains only two peaks by UV spectrometry. Further purification and characterization of this peptide(s) from additional IC patients is the first priority, with attempts to determine whether it is excreted into the urine or produced by cells from the upper or lower urinary tract. Whether the peptide(s) is glycosylated and the general types of sugar moieties present will also be assessed, and its antiproliferative activity confirmed by blocking experiments using monospecific polyclonal rabbit antibodies. The role of this peptide(s) in the pathogenesis of IC will be evaluated by correlating the amount of the peptide(s) with cystometric findings and/or symptom, severity in IC patients. Data from these studies should provide valuable information regarding the possible role of a specific urine peptide(s) in bladder epithelial cell proliferation and disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK052596-03
Application #
2906007
Study Section
Special Emphasis Panel (ZRG4-UROL (01))
Program Officer
Mullins, Christopher V
Project Start
1997-09-30
Project End
2001-03-31
Budget Start
1999-09-01
Budget End
2001-03-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
003255213
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Yang, Wei; Kim, Yongsoo; Kim, Taek-Kyun et al. (2012) Integration analysis of quantitative proteomics and transcriptomics data identifies potential targets of frizzled-8 protein-related antiproliferative factor in vivo. BJU Int 110:E1138-46
Kim, Jayoung; Keay, Susan K; You, Sungyong et al. (2012) A synthetic form of frizzled 8-associated antiproliferative factor enhances p53 stability through USP2a and MDM2. PLoS One 7:e50392
Kim, Jayoung; Ji, Mihee; DiDonato, Joseph A et al. (2011) An hTERT-immortalized human urothelial cell line that responds to anti-proliferative factor. In Vitro Cell Dev Biol Anim 47:2-9
Yang, Wei; Chung, Yeun Goo; Kim, Yongsoo et al. (2011) Quantitative proteomics identifies a beta-catenin network as an element of the signaling response to Frizzled-8 protein-related antiproliferative factor. Mol Cell Proteomics 10:M110.007492
Keay, Susan; Kaczmarek, Piotr; Zhang, Chen-Ou et al. (2011) Normalization of proliferation and tight junction formation in bladder epithelial cells from patients with interstitial cystitis/painful bladder syndrome by d-proline and d-pipecolic acid derivatives of antiproliferative factor. Chem Biol Drug Des 77:421-30
Kim, Jayoung; Keay, Susan K; Freeman, Michael R (2009) Heparin-binding epidermal growth factor-like growth factor functionally antagonizes interstitial cystitis antiproliferative factor via mitogen-activated protein kinase pathway activation. BJU Int 103:541-6
Sun, Yan; Keay, Susan; Lehrfeld, Todd J et al. (2009) Changes in adenosine triphosphate-stimulated ATP release suggest association between cytokine and purinergic signaling in bladder urothelial cells. Urology 74:1163-8
Planey, Sonia L; Keay, Susan K; Zhang, Chen-Ou et al. (2009) Palmitoylation of cytoskeleton associated protein 4 by DHHC2 regulates antiproliferative factor-mediated signaling. Mol Biol Cell 20:1454-63
Kaczmarek, Piotr; Keay, Susan K; Tocci, Gillian M et al. (2008) Structure-activity relationship studies for the peptide portion of the bladder epithelial cell antiproliferative factor from interstitial cystitis patients. J Med Chem 51:5974-83
Kim, Jayoung; Keay, Susan K; Dimitrakov, Jordan D et al. (2007) p53 mediates interstitial cystitis antiproliferative factor (APF)-induced growth inhibition of human urothelial cells. FEBS Lett 581:3795-9

Showing the most recent 10 out of 21 publications